272 related articles for article (PubMed ID: 32013627)
1. The dry powder inhaler features of the Easyhaler that benefit the management of patients.
Chrystyn H; Lavorini F
Expert Rev Respir Med; 2020 Apr; 14(4):345-351. PubMed ID: 32013627
[No Abstract] [Full Text] [Related]
2. Easyhaler
Lavorini F
Drugs Context; 2019; 8():212596. PubMed ID: 31210773
[TBL] [Abstract][Full Text] [Related]
3. Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease.
Bagherisadeghi G; Chrystyn H; Abadelah M; Larhrib EH
Eur J Pharm Sci; 2019 Nov; 139():105059. PubMed ID: 31472254
[TBL] [Abstract][Full Text] [Related]
4. Budesonide + formoterol delivered via Spiromax
Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
[TBL] [Abstract][Full Text] [Related]
5. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study.
Ferguson GT; Tashkin DP; Skärby T; Jorup C; Sandin K; Greenwood M; Pemberton K; Trudo F
Respir Med; 2017 Nov; 132():31-41. PubMed ID: 29229103
[TBL] [Abstract][Full Text] [Related]
6. Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study.
Janson C; Lööf T; Telg G; Stratelis G; Nilsson F
NPJ Prim Care Respir Med; 2016 Nov; 26():16053. PubMed ID: 27853177
[TBL] [Abstract][Full Text] [Related]
7. Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
Karjalainen J; Vartiainen V; Tikkakoski A; Malmberg LP; Vuotari L; Lähelmä S; Sairanen U; Vahteristo M; Lehtimäki L
Respir Med; 2024; 230():107693. PubMed ID: 38851404
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.
Price DB; Thomas V; Richard Dekhuijzen PN; Bosnic-Anticevich S; Roche N; Lavorini F; Raju P; Freeman D; Nicholls C; Small IR; Sims E; Safioti G; Canvin J; Chrystyn H
BMC Pulm Med; 2018 Jun; 18(1):107. PubMed ID: 29954359
[TBL] [Abstract][Full Text] [Related]
9. Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Turbuhaler.
Lähelmä S; Sairanen U; Haikarainen J; Korhonen J; Vahteristo M; Fuhr R; Kirjavainen M
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):462-73. PubMed ID: 25757188
[TBL] [Abstract][Full Text] [Related]
10. The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.
Lewis A; Torvinen S; Dekhuijzen PN; Chrystyn H; Watson AT; Blackney M; Plich A
BMC Health Serv Res; 2016 Jul; 16():251. PubMed ID: 27406133
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of in vitro and in vivo flow rate dependency of budesonide/formoterol Easyhaler(®).
Malmberg LP; Everard ML; Haikarainen J; Lähelmä S
J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):329-40. PubMed ID: 24978441
[TBL] [Abstract][Full Text] [Related]
12. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler
Tamási L; Szilasi M; Gálffy G
Adv Ther; 2018 Aug; 35(8):1140-1152. PubMed ID: 30066185
[TBL] [Abstract][Full Text] [Related]
13. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler
Syk J; Vinge I; Sörberg M; Vahteristo M; Rytilä P
Adv Ther; 2019 Jul; 36(7):1756-1769. PubMed ID: 30941722
[TBL] [Abstract][Full Text] [Related]
14. Onset of action of budesonide/formoterol Spiromax(®) compared with budesonide/formoterol Turbuhaler(®) in patients with COPD.
Cazzola M; Ora J; Di Paolo A; Puxeddu E; Calzetta L; Rogliani P
Pulm Pharmacol Ther; 2016 Aug; 39():48-53. PubMed ID: 27344046
[TBL] [Abstract][Full Text] [Related]
15. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.
Gálffy G; Mezei G; Németh G; Tamási L; Müller V; Selroos O; Orosz M
Drugs R D; 2013 Sep; 13(3):215-22. PubMed ID: 24043456
[TBL] [Abstract][Full Text] [Related]
16. Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK.
Voorham J; Roche N; Benhaddi H; van der Tol M; Carter V; van Boven JFM; Bjermer L; Miravitlles M; Price DB
BMJ Open; 2018 Oct; 8(10):e022051. PubMed ID: 30368448
[TBL] [Abstract][Full Text] [Related]
17. Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD.
De Simón Gutiérrez R; Castro RP
Curr Allergy Asthma Rep; 2022 Nov; 22(11):151-161. PubMed ID: 36087251
[TBL] [Abstract][Full Text] [Related]
18. An innovative corticosteroid/long-acting β
Usmani O; Roche N; Marshall J; Danagher H; Price D
Expert Opin Drug Deliv; 2019 Dec; 16(12):1367-1380. PubMed ID: 31752560
[No Abstract] [Full Text] [Related]
19. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair
Yildiz P; Bayraktaroglu M; Gorgun D; Yuksel K
Clin Drug Investig; 2019 Oct; 39(10):991-1001. PubMed ID: 31332649
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in Turkey.
Öztürk C; Kaya A; Bilgin C; Yücesoy L; İkidağ B; Demirel M; Başlılar Ş; Şaylan B; Senol T; Ağanoğlu S; Can G; Doğrul MI; Çam M; Erdoğan N; Batum Ö; Turan MO; Demir C; Torun Ş; Cirit M; Turan M; Keleşoğlu A; Yaşar S; Uzunay Ö; Melek K; Altıparmak O
Tuberk Toraks; 2012; 60(4):301-13. PubMed ID: 23289459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]